Goldman Sachs analyst Mark Delaney lowered the firm’s price target on Aptiv (APTV) to $71 from $86 and keeps a Buy rating on the shares. The firm lowered target multiples for Aptiv and Visteon (VC) reflecting challenging industry trends, including for electric vehicles.